Cargando…

Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia

Recently, great progress has been achieved in the treatment of chronic lymphocytic leukemia (CLL). However, some patients, particularly older patients with comorbidities or with relapsed/refractory leukemia, still have limited therapeutic options. There is an urgent need to discover less toxic and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Podhorecka, Monika, Macheta, Arkadiusz, Chocholska, Sylwia, Bojarska-Junak, Agnieszka, Szymczyk, Agnieszka, Goracy, Aneta, Dmoszynska, Anna, Hus, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742499/ https://www.ncbi.nlm.nih.gov/pubmed/26692089 http://dx.doi.org/10.1007/s00277-015-2579-5

Ejemplares similares

Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients
por: Szymczyk, Agnieszka, et al.
Publicado: (2019)

Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease
por: Szymczyk, Agnieszka, et al.
Publicado: (2018)

The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia
por: Podhorecka, Monika, et al.
Publicado: (2015)

Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia
por: Podhorecka, Monika, et al.
Publicado: (2016)

Changes in T-cell subpopulations and cytokine network during early period of ibrutinib therapy in chronic lymphocytic leukemia patients: the significant decrease in T regulatory cells number
por: Podhorecka, Monika, et al.
Publicado: (2017)

Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells
por: Podhorecka, Monika, et al.
Publicado: (2010)

Th17/IL-17A Might Play a Protective Role in Chronic Lymphocytic Leukemia Immunity
por: Hus, Iwona, et al.
Publicado: (2013)

TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia
por: Szymańska, Agata, et al.
Publicado: (2018)

Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
por: Podhorecka, Monika, et al.
Publicado: (2010)

Abnormal microRNA expression in the course of hematological malignancies
por: Szymczyk, Agnieszka, et al.
Publicado: (2018)

Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia
por: Bojarska-Junak, Agnieszka, et al.
Publicado: (2018)

Programmed Death-1 and Its Ligand Are Novel Immunotolerant Molecules Expressed on Leukemic B Cells in Chronic Lymphocytic Leukemia
por: Grzywnowicz, Maciej, et al.
Publicado: (2012)

Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia
por: Chocholska, Sylwia, et al.
Publicado: (2023)

Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
por: Zdzisińska, Barbara, et al.
Publicado: (2008)

High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia
por: Zarobkiewicz, Michał, et al.
Publicado: (2020)

Prognostic Value of Tie2-Expressing Monocytes in Chronic Lymphocytic Leukemia Patients
por: Woś, Justyna, et al.
Publicado: (2021)

Prognostic Potential of Galectin-9 mRNA Expression in Chronic Lymphocytic Leukemia
por: Bojarska-Junak, Agnieszka, et al.
Publicado: (2023)

Tricyclic Nucleobase Analogs and Their Ribosides as Substrates and Inhibitors of Purine-Nucleoside Phosphorylases III. Aminopurine Derivatives
por: Stachelska-Wierzchowska, Alicja, et al.
Publicado: (2020)

Diverse models for anti-HIV activity of purine nucleoside analogs
por: Khatri, Naveen, et al.
Publicado: (2015)

Efficient Synthesis of Purine Nucleoside Analogs by a New Trimeric Purine Nucleoside Phosphorylase from Aneurinibacillus migulanus AM007
por: Liu, Gaofei, et al.
Publicado: (2019)

Association of Common Variants of TNFSF13 and TNFRSF13B Genes with CLL Risk and Clinical Picture, as Well as Expression of Their Products—APRIL and TACI Molecules
por: Jasek, Monika, et al.
Publicado: (2020)

Tri-Cyclic Nucleobase Analogs and Their Ribosides as Substrates of Purine-Nucleoside Phosphorylases. II Guanine and Isoguanine Derivatives
por: Stachelska-Wierzchowska, Alicja, et al.
Publicado: (2019)

Site-Selective Ribosylation of Fluorescent Nucleobase Analogs Using Purine-Nucleoside Phosphorylase as a Catalyst: Effects of Point Mutations
por: Stachelska-Wierzchowska, Alicja, et al.
Publicado: (2015)

Enhancement of Peripheral Nerve Regrowth by the Purine Nucleoside Analog and Cell Cycle Inhibitor, Roscovitine
por: Law, Vincent, et al.
Publicado: (2016)

The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
por: Stefaniuk, Paulina, et al.
Publicado: (2020)

In Pursuit of Genetic Prognostic Factors and Treatment Approaches in Secondary Acute Myeloid Leukemia—A Narrative Review of Current Knowledge
por: Stefaniuk, Paulina, et al.
Publicado: (2022)

Purine nucleosides: endogenous neuroprotectants in hypoxic brain
por: Thauerer, Bettina, et al.
Publicado: (2012)

Synthesis of a 3′-C-ethynyl-β-d-ribofuranose purine nucleoside library: Discovery of C7-deazapurine analogs as potent antiproliferative nucleosides
por: Hulpia, Fabian, et al.
Publicado: (2018)

In Vitro Immunomodulatory Activity of a Transition-State Analog Inhibitor of Human Purine Nucleoside Phosphorylase in Cutaneous Leishmaniasis
por: Carvalho, Natália Barbosa, et al.
Publicado: (2017)

In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia
por: Giannopoulos, Krzysztof, et al.
Publicado: (2021)

A brief review of clinical trials involving manipulation of invariant NKT cells as a promising approach in future cancer therapies
por: Waldowska, Małgorzata, et al.
Publicado: (2017)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
por: Zarobkiewicz, Michał K., et al.
Publicado: (2022)

Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2021)

Addendum: Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2023)

Interactions of 2,6-substituted purines with purine nucleoside phosphorylase from Helicobacter pylori in solution and in the crystal, and the effects of these compounds on cell cultures of this bacterium
por: Narczyk, Marta, et al.
Publicado: (2022)

Purine Nucleoside Analog - Sulfinosine Modulates Diverse Mechanisms of Cancer Progression in Multi-Drug Resistant Cancer Cell Lines
por: Dačević, Mirjana, et al.
Publicado: (2013)

Purine nucleoside phosphorylase is associated with centrioles and basal bodies
Publicado: (1981)

Conservation of structure and activity in Plasmodium purine nucleoside phosphorylases
por: Chaikuad, Apirat, et al.
Publicado: (2009)

Thermus thermophilus Strains Active in Purine Nucleoside Synthesis
por: Almendros, Marcos, et al.
Publicado: (2009)

Antiviral nucleoside analogs
por: Kataev, Vladimir E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_573lpalp3iimpgdu4bkt9mj2l8